1st Edition

Nanomedicine, Volume IIA Biocompatibility

By Robert A. Freitas Copyright 2003
    366 Pages 15 B/W Illustrations
    by CRC Press

    The safety, effectiveness, and utility of medical nanorobotic devices will critically depend upon their biocompatibility with human organs, tissues, cells, and biochemical systems. In this Volume, we broaden the definition of nanomedical biocompatibility to include all of the mechanical, physiological, immunological, cytological, and biochemical responses of the human body to the introduction of artificial medical nanodevices, whether “particulate” (large doses of independent micron-sized individual nanorobots) or “bulk” (nanorobotic organs assembled either as solid objects or built up from trillions of smaller artificial cells or docked nanorobots inside the body) in form.

    Preface Chapter 15.1. Are Diamondoid Nanorobot Hazardous? Chapter 15.2. Classical Biocompatibility Chapter 15.3. Biocompatibility of Nanomedical Materials Chapter 15.4. Systemic Nanorobot Distribution and Phagocytosis Chapter 15.5. Nanorobot Mechanocompatibility Chapter 15.6. Nanorobot Volumetric Intrusiveness

    Biography

    Robert A. Freitas, Research Scientist, Zyvex Corporation, Richardson, Texas, U.S.A.